RA Capital's $1.56M open-market purchase is a strong bullish signal from a sophisticated healthcare investor.
ARTV drugs
ARTV drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 21 $10.00entry
- T+1 · 4mo ago +0.20%α +0.32% · $10.02
- T+5 · 4mo ago +3.20%α +4.43% · $10.32
- T+20 · 3mo ago +16.80%α +14.24% · $11.68
- T+60 · 5w ago −40.90%α −43.75% · $5.91
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
RA Capital Management, a 10% owner and director, purchased $1.56M in ARTV stock over a week, including a $1.36M block on July 16. This is a significant insider conviction buy at ~0.65% of market cap, signaling strong confidence from a sophisticated healthcare investor ahead of potential catalysts.
Key Financial Metrics
Key Facts
- RA Capital Management (10% owner/director) purchased $1.56M in ARTV stock from July 10-16
- Largest single trade: 152,472 shares at $8.93 for $1.36M on July 16
- Total insider buying over 30 days: $1.9M across 6 transactions
- Market cap: $241M; purchase represents ~0.65% of market cap
- 92% analyst consensus bullish (11 of 12 analysts rate Buy or Strong Buy)
Financial Impact
Insider purchase of $1.56M represents 0.65% of market cap, a significant signal from a 10% owner
Risk Factors
- Biotech sector risk: clinical-stage company with no approved products
- Insider buying concentrated in one 10% owner; not a broad C-suite cluster
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001231919-26-000774 |
Track record
33 reports on ARTV
10 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
- Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
- Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
- Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
- Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers